Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react-Reference-Cited by-同舟云学术

Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react

Published:2014-12-19 Issue:2 Volume:169 Page:249-261
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Pochon Cécile¹,Oger Emmanuel²,Michel Gérard³,Dalle Jean-Hugues⁴,Salmon Alexandra¹,Nelken Brigitte⁵,Bertrand Yves⁶,Cavé Hélène⁷,Cayuela Jean-Michel⁸,Grardel Nathalie⁹,Macintyre Elizabeth¹⁰,Margueritte Geneviève¹¹,Méchinaud Françoise¹²,Rohrlich Pierre¹³,Paillard Catherine¹⁴,Demeocq François¹⁵,Schneider Pascale¹⁶,Plantaz Dominique¹⁷,Poirée Marilyne¹⁸,Eliaou Jean-François¹⁹,Semana Gilbert²⁰,Drunat Séverine⁷,Jonveaux Philippe²¹,Bordigoni Pierre¹,Gandemer Virginie²²

Affiliation:

1. Department of Paediatric Haematology/oncology; University Hospital of Nancy; Nancy France

2. Clinical Pharmacology Department; Pharmacoepidemiology Team; University Hospital of Rennes; Rennes France

3. Department of Paediatric Haematology; University Hospital of La Timone; Marseille France

4. Department of Paediatric Haematology; University Hospital of Robert Debré; Paris France

5. Department of Paediatric Haematology/Oncology; University Hospital of Jeanne de Flandre; Lille France

6. Department of Paediatric Haematology; Hospices Civils de Lyon; Lyon France

7. Department of Genetics; University Hospital of Robert Debré and Paris-Diderot University; Paris France

8. Laboratory of Haematology; University Hospital of St Louis; Paris France

9. Laboratory of Haematology; University Hospital of Calmette; Lille France

10. Laboratory of Haematology; University Hospital of Necker; Paris France

11. Department of Paediatric Haematology/Oncology; University Hospital of Villeneuve; Montpellier France

12. Department of Paediatric Haematology/Oncology; University Hospital of Nantes; Nantes France

13. Department of Paediatric Haematology/Oncology; University Hospital of Besançon; Besançon France

14. Department of Paediatric Haematology/Oncology; University Hospital of Hautepierre; Strasbourg France

15. Department of Paediatric Haematology/oncology; University Hospital of Clermont-Ferrand; Clermont-Ferrand France

16. Department of Paediatric Haematology; University Hospital of Rouen; Rouen France

17. Department of Paediatric Haematology/oncology; University Hospital of La Tronche; Grenoble France

18. Department of Paediatric Haematology/oncology; University Hospital of Archet II; Nice France

19. Laboratory of Immunology; University Hospital of Montpellier; Montpellier France

20. Laboratory of Immunology; French blood transfusion centre; Rennes France

21. Department of Genetics; University Hospital of Nancy; Nancy France

22. Department of paediatric Haematology/Oncology; University Hospital of Rennes; Rennes France

Funder

Public Health Research Programme

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13272/fullpdf

Reference25 articles.

1. Increasing mixed is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?;Bader;Journal of Clinical Oncology,2004

2. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group;Bader;Journal of Clinical Oncology,2009

3. Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?;Balduzzi;British Journal of Haematology,2014

4. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia;Barrios;Haematologica,2003

5. Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation;Campana;British Journal of Haematology,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia;Best Practice & Research Clinical Haematology;2023-09

2. Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?;Frontiers in Pediatrics;2022-03-24

3. Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?;Frontiers in Pediatrics;2021-11-05

4. A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation;Chinese Medical Journal;2021-03-12

5. Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia;Bone Marrow Transplantation;2020-01-30